Intrauterine Devices Market By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing IUD), By Age Group (15-24 years, 25-34 years, 35-44 years, Above 44 years), By End User (Hospitals, Clinics, Community Health Care Centres, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global intrauterine devices market was valued at $2,992.73 million in 2021 and is projected to reach $4,374.3 million by 2031, registering a CAGR of 3.8% from 2022 to 2031. An intrauterine device (IUD) is a small plastic T-shaped device used for birth control. It is inserted into the uterus where it stays to prevent pregnancy. The intrauterine device is one form of long-acting reversible birth control (LARC) that is also safe and effective in adolescents as well as those who have not previously had children. Once an intrauterine device is removed, even after long-term use, fertility returns to normal rapidly. There are two types of intrauterine devices available on the market including nonhormonal: copper-containing IUD and hormonal: progestogen-releasing IUD to prevent unwanted pregnancies.
The global intrauterine devices market is segmented on the basis of type, age group, end-user, and region. Based on type, the market is classified into nonhormonal: copper-containing IUDs and hormonal: progestogen-releasing IUDs. By age group, it is categorized into 15–24 years, 25–34 years, 35–44 years, and above 44 years. By end-user, it is classified into hospitals, community health centers, clinics, and others. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The major factors that drive the growth of the market are an increase in focus on family planning and the need for preventing unintended pregnancy. The advancement in hormonal intrauterine devices with enhanced efficacy and fewer side effects are expected to further boost the market growth. Moreover, health issues associated with teenage pregnancies, an increase in awareness of intrauterine device methods method to prevent unplanned pregnancy fuel the market growth. However, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect the market growth.
The key players operating in the global intrauterine devices market include the AbbVie Inc.(Allergan Plc) , Bayer AG, Cooper Companies Inc, DKT International, Mona Lisa NV ( EurimPharma Group) , Ocon Healthcare, Pregana International Ltd, Prosan International B.V. Eurogine SL and Viatris Inc. (Mylan NV).
In 2021, Asia Pacific was the major revenue generator, owing to the presence of a large population, increase in awareness of the benefits of using hormonal intrauterine devices, high prevalence of unwanted pregnancy, and favorable regulatory scenario. However, North America is the second-largest revenue generator in 2021, due to the presence of. healthcare infrastructure and rising awareness pertaining to the usage of IUDs.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intrauterine devices market analysis from 2021 to 2031 to identify the prevailing intrauterine devices market opportunities.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the intrauterine devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global intrauterine devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Nonhormonal: Copper-containing IUD
Hormonal: Progestogen-releasing IUD
By Age Group
25-34 years
35-44 years
Above 44 years
15-24 years
By End User
Hospitals
Clinics
Community Health Care Centres
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Bayer AG
CooperSurgical Inc
DKT International
Mona Lisa NV
Pregna International Limited
Prosan International BV
Abviee Inc
Eurogine, S.L.
Viatris Inc
Mona Lisa N.V.,
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: INTRAUTERINE DEVICES MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Nonhormonal: Copper-containing IUD
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Hormonal: Progestogen-releasing IUD
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: INTRAUTERINE DEVICES MARKET, BY AGE GROUP
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 15-24 years
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 25-34 years
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 35-44 years
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Above 44 years
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: INTRAUTERINE DEVICES MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Clinics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Community Health Care Centres
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- CHAPTER 7: INTRAUTERINE DEVICES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Age Group
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Age Group
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Age Group
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Age Group
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Age Group
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Age Group
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Age Group
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Age Group
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Age Group
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Age Group
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Age Group
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Age Group
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Age Group
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Age Group
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Age Group
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Age Group
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Age Group
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest Of Asia Pacific
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Age Group
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Age Group
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Age Group
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Age Group
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Age Group
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Age Group
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Bayer AG
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 CooperSurgical Inc
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 DKT International
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Mona Lisa NV
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Pregna International Limited
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Prosan International BV
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Abviee Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Eurogine, S.L.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Viatris Inc
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Mona Lisa N.V.,
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. INTRAUTERINE DEVICES MARKET SIZE, FOR NONHORMONAL: COPPER-CONTAINING IUD, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. INTRAUTERINE DEVICES MARKET FOR NONHORMONAL: COPPER-CONTAINING IUD BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. INTRAUTERINE DEVICES MARKET SIZE, FOR HORMONAL: PROGESTOGEN-RELEASING IUD, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. INTRAUTERINE DEVICES MARKET FOR HORMONAL: PROGESTOGEN-RELEASING IUD BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 7. INTRAUTERINE DEVICES MARKET SIZE, FOR 15-24 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. INTRAUTERINE DEVICES MARKET FOR 15-24 YEARS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. INTRAUTERINE DEVICES MARKET SIZE, FOR 25-34 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. INTRAUTERINE DEVICES MARKET FOR 25-34 YEARS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. INTRAUTERINE DEVICES MARKET SIZE, FOR 35-44 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. INTRAUTERINE DEVICES MARKET FOR 35-44 YEARS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. INTRAUTERINE DEVICES MARKET SIZE, FOR ABOVE 44 YEARS, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. INTRAUTERINE DEVICES MARKET FOR ABOVE 44 YEARS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 15. GLOBAL INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 16. INTRAUTERINE DEVICES MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. INTRAUTERINE DEVICES MARKET FOR HOSPITALS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. INTRAUTERINE DEVICES MARKET SIZE, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. INTRAUTERINE DEVICES MARKET FOR CLINICS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. INTRAUTERINE DEVICES MARKET SIZE, FOR COMMUNITY HEALTH CARE CENTRES, BY REGION, 2021-2031 ($MILLION)
- TABLE 21. INTRAUTERINE DEVICES MARKET FOR COMMUNITY HEALTH CARE CENTRES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 22. INTRAUTERINE DEVICES MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 23. INTRAUTERINE DEVICES MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 24. INTRAUTERINE DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. NORTH AMERICA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 26. NORTH AMERICA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 27. NORTH AMERICA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 28. NORTH AMERICA INTRAUTERINE DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. U.S. INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 30. U.S. INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 31. U.S. INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 32. CANADA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 33. CANADA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 34. CANADA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 35. MEXICO INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 36. MEXICO INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 37. MEXICO INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. EUROPE INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 39. EUROPE INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 40. EUROPE INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 41. EUROPE INTRAUTERINE DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 42. GERMANY INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 43. GERMANY INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 44. GERMANY INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 45. FRANCE INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 46. FRANCE INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 47. FRANCE INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 48. U.K. INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 49. U.K. INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 50. U.K. INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. ITALY INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 52. ITALY INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 53. ITALY INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 54. SPAIN INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 55. SPAIN INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 56. SPAIN INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 57. REST OF EUROPE INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 58. REST OF EUROPE INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 59. REST OF EUROPE INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 60. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 61. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 62. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 63. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 64. JAPAN INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 65. JAPAN INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 66. JAPAN INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 67. CHINA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 68. CHINA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 69. CHINA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 70. AUSTRALIA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 71. AUSTRALIA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 72. AUSTRALIA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 73. INDIA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 74. INDIA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 75. INDIA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 76. SOUTH KOREA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 77. SOUTH KOREA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 78. SOUTH KOREA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 79. REST OF ASIA PACIFIC INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 80. REST OF ASIA PACIFIC INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 81. REST OF ASIA PACIFIC INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 82. LAMEA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 83. LAMEA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 84. LAMEA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 85. LAMEA INTRAUTERINE DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 86. BRAZIL INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 87. BRAZIL INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 88. BRAZIL INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 89. SAUDI ARABIA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 90. SAUDI ARABIA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 91. SAUDI ARABIA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 92. SOUTH AFRICA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 93. SOUTH AFRICA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 94. SOUTH AFRICA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 95. REST OF LAMEA INTRAUTERINE DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 96. REST OF LAMEA INTRAUTERINE DEVICES MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
- TABLE 97. REST OF LAMEA INTRAUTERINE DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 98.BAYER AG: COMPANY SNAPSHOT
- TABLE 99.BAYER AG: OPERATING SEGMENTS
- TABLE 100.BAYER AG: PRODUCT PORTFOLIO
- TABLE 101.BAYER AG: NET SALES,
- TABLE 102.BAYER AG: KEY STRATERGIES
- TABLE 103.COOPERSURGICAL INC: COMPANY SNAPSHOT
- TABLE 104.COOPERSURGICAL INC: OPERATING SEGMENTS
- TABLE 105.COOPERSURGICAL INC: PRODUCT PORTFOLIO
- TABLE 106.COOPERSURGICAL INC: NET SALES,
- TABLE 107.COOPERSURGICAL INC: KEY STRATERGIES
- TABLE 108.DKT INTERNATIONAL: COMPANY SNAPSHOT
- TABLE 109.DKT INTERNATIONAL: OPERATING SEGMENTS
- TABLE 110.DKT INTERNATIONAL: PRODUCT PORTFOLIO
- TABLE 111.DKT INTERNATIONAL: NET SALES,
- TABLE 112.DKT INTERNATIONAL: KEY STRATERGIES
- TABLE 113.MONA LISA NV: COMPANY SNAPSHOT
- TABLE 114.MONA LISA NV: OPERATING SEGMENTS
- TABLE 115.MONA LISA NV: PRODUCT PORTFOLIO
- TABLE 116.MONA LISA NV: NET SALES,
- TABLE 117.MONA LISA NV: KEY STRATERGIES
- TABLE 118.PREGNA INTERNATIONAL LIMITED: COMPANY SNAPSHOT
- TABLE 119.PREGNA INTERNATIONAL LIMITED: OPERATING SEGMENTS
- TABLE 120.PREGNA INTERNATIONAL LIMITED: PRODUCT PORTFOLIO
- TABLE 121.PREGNA INTERNATIONAL LIMITED: NET SALES,
- TABLE 122.PREGNA INTERNATIONAL LIMITED: KEY STRATERGIES
- TABLE 123.PROSAN INTERNATIONAL BV: COMPANY SNAPSHOT
- TABLE 124.PROSAN INTERNATIONAL BV: OPERATING SEGMENTS
- TABLE 125.PROSAN INTERNATIONAL BV: PRODUCT PORTFOLIO
- TABLE 126.PROSAN INTERNATIONAL BV: NET SALES,
- TABLE 127.PROSAN INTERNATIONAL BV: KEY STRATERGIES
- TABLE 128.ABVIEE INC: COMPANY SNAPSHOT
- TABLE 129.ABVIEE INC: OPERATING SEGMENTS
- TABLE 130.ABVIEE INC: PRODUCT PORTFOLIO
- TABLE 131.ABVIEE INC: NET SALES,
- TABLE 132.ABVIEE INC: KEY STRATERGIES
- TABLE 133.EUROGINE, S.L.: COMPANY SNAPSHOT
- TABLE 134.EUROGINE, S.L.: OPERATING SEGMENTS
- TABLE 135.EUROGINE, S.L.: PRODUCT PORTFOLIO
- TABLE 136.EUROGINE, S.L.: NET SALES,
- TABLE 137.EUROGINE, S.L.: KEY STRATERGIES
- TABLE 138.VIATRIS INC: COMPANY SNAPSHOT
- TABLE 139.VIATRIS INC: OPERATING SEGMENTS
- TABLE 140.VIATRIS INC: PRODUCT PORTFOLIO
- TABLE 141.VIATRIS INC: NET SALES,
- TABLE 142.VIATRIS INC: KEY STRATERGIES
- TABLE 143.MONA LISA N.V.,: COMPANY SNAPSHOT
- TABLE 144.MONA LISA N.V.,: OPERATING SEGMENTS
- TABLE 145.MONA LISA N.V.,: PRODUCT PORTFOLIO
- TABLE 146.MONA LISA N.V.,: NET SALES,
- TABLE 147.MONA LISA N.V.,: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.INTRAUTERINE DEVICES MARKET SEGMENTATION
- FIGURE 2.INTRAUTERINE DEVICES MARKET,2021-2031
- FIGURE 3.INTRAUTERINE DEVICES MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.INTRAUTERINE DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.INTRAUTERINE DEVICES MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NONHORMONAL: COPPER-CONTAINING IUD INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HORMONAL: PROGESTOGEN-RELEASING IUD INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 15.INTRAUTERINE DEVICES MARKET,BY AGE GROUP,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF 15-24 YEARS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF 25-34 YEARS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF 35-44 YEARS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ABOVE 44 YEARS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 20.INTRAUTERINE DEVICES MARKET,BY END USER,2021(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF CLINICS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF COMMUNITY HEALTH CARE CENTRES INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRAUTERINE DEVICES MARKET,2021-2031(%)
- FIGURE 25.INTRAUTERINE DEVICES MARKET BY REGION,2021
- FIGURE 26.U.S. INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 31.U.K. INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 35.JAPAN INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 36.CHINA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 37.AUSTRALIA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 38.INDIA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF ASIA PACIFIC INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 41.BRAZIL INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 42.SAUDI ARABIA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH AFRICA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF LAMEA INTRAUTERINE DEVICES MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.BAYER AG.: NET SALES ,($MILLION)
- FIGURE 52.COOPERSURGICAL INC.: NET SALES ,($MILLION)
- FIGURE 53.DKT INTERNATIONAL.: NET SALES ,($MILLION)
- FIGURE 54.MONA LISA NV.: NET SALES ,($MILLION)
- FIGURE 55.PREGNA INTERNATIONAL LIMITED.: NET SALES ,($MILLION)
- FIGURE 56.PROSAN INTERNATIONAL BV.: NET SALES ,($MILLION)
- FIGURE 57.ABVIEE INC.: NET SALES ,($MILLION)
- FIGURE 58.EUROGINE, S.L..: NET SALES ,($MILLION)
- FIGURE 59.VIATRIS INC.: NET SALES ,($MILLION)
- FIGURE 60.MONA LISA N.V.,.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook